Upregulation of Nrf2 has been shown to improve cardiac oxidative stress, making it an ideal target for cardiac adjuvant therapy, especially in preventing hyperglycemia-induced development of DCM, which is closely related to uncontrolled oxidative stress [42]. Here, NFE2L2 is linked to Hyperglycemia.